Ibrahim Sultan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ibrahim Sultan has a total of 680 co-authors. Here are the top co-authors by number of shared publications:
Derek Serna-Gallegos
Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, United States; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, United States
91 shared publicationsJames A. Brown
Department of Cardiothoracic Surgery, Division of Cardiac Surgery University of Pittsburgh Pittsburgh Pennsylvania USA
74 shared publicationsForozan Navid
Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
69 shared publicationsArman Kilic
Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
65 shared publicationsEdgar Aranda-Michel
Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA
65 shared publicationsThomas G. Gleason
Division of Cardiac Surgery, Department of Surgery, University of Maryland, College Park, Md
61 shared publications
Latest Publications
- Open Access
- 20 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102721
Impact of Female Sex on Survival and Outcomes After Mitral Valve Surgery
- 20 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102721
Open AccessImpact of Female Sex on Survival and Outcomes After Mitral Valve Surgery
- 18 May 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (4) , 1000-1010.e9
Long-term outcomes of postoperative atrial fibrillation after cardiac surgery: Results from 19,000 patients
- 18 May 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (4) , 1000-1010.e9
Long-term outcomes of postoperative atrial fibrillation after cardiac surgery: Results from 19,000 patients
- Open Access
- 23 April 2026
- Published by IMR Press in The Heart Surgery Forum
- Vol. 29 (4)
Surgical Versus Transcatheter Aortic Valve Replacement in Low-Flow, Low-Gradient Aortic Stenosis: Results From 1900 Patients
Background: Low-flow, low-gradient (LFLG) aortic stenosis (AS) is associated with high-risk physiology and poor outcomes; however, the optimal intervention strategy, surgical aortic valve replacement (SAVR) versus transcatheter aortic valve replacement (TAVR), remains uncertain. Methods: A systematic review and pooled meta-analysis of studies reporting Kaplan-Meier outcomes after SAVR and TAVR in patients with LFLG AS, published through June 2025, was performed. Individual patient data were reconstructed from published curves. Analyses included Cox frailty models, restricted mean survival time (RMST), and two-stage meta-analyses. Adjusted analyses accounted for baseline differences, including age, comorbidities, and echocardiographic parameters. Results: Five studies comprising 1940 patients (721 SAVR and 1219 TAVR) were included. Patients undergoing TAVR were older and had higher rates of peripheral arterial disease, while other comorbidities and echocardiographic parameters were similar between groups. In unadjusted analyses, TAVR was associated with higher mortality compared with SAVR (hazard ratio (HR) 1.36, 95% confidence interval (CI) 1.11–1.65; p = 0.003). The estimated 5-year survival was 67% for SAVR versus 49% for TAVR, with an RMST of 0.64 years in favor of SAVR. Despite risk adjustment, TAVR was associated with higher mortality (HR 1.42, 95% CI 1.17–1.73), with a reduction in RMST of 1.06 years. Two-stage meta-analyses yielded consistent findings with low-to-moderate heterogeneity. Conclusion: SAVR was associated with significantly lower mortality in patients with LFLG AS than TAVR, both before and after risk adjustment. While these findings suggest a potential survival benefit, the data are observational and hypothesis-generating, and residual confounding cannot be excluded.
- 23 April 2026
- Published by IMR Press in The Heart Surgery Forum
- Vol. 29 (4)
Open AccessSurgical Versus Transcatheter Aortic Valve Replacement in Low-Flow, Low-Gradient Aortic Stenosis: Results From 1900 Patients
Background: Low-flow, low-gradient (LFLG) aortic stenosis (AS) is associated with high-risk physiology and poor outcomes; however, the optimal intervention strategy, surgical aortic valve replacement (SAVR) versus transcatheter aortic valve replacement (TAVR), remains uncertain. Methods: A systematic review and pooled meta-analysis of studies reporting Kaplan-Meier outcomes after SAVR and TAVR in patients with LFLG AS, published through June 2025, was performed. Individual patient data were reconstructed from published curves. Analyses included Cox frailty models, restricted mean survival time (RMST), and two-stage meta-analyses. Adjusted analyses accounted for baseline differences, including age, comorbidities, and echocardiographic parameters. Results: Five studies comprising 1940 patients (721 SAVR and 1219 TAVR) were included. Patients undergoing TAVR were older and had higher rates of peripheral arterial disease, while other comorbidities and echocardiographic parameters were similar between groups. In unadjusted analyses, TAVR was associated with higher mortality compared with SAVR (hazard ratio (HR) 1.36, 95% confidence interval (CI) 1.11–1.65; p = 0.003). The estimated 5-year survival was 67% for SAVR versus 49% for TAVR, with an RMST of 0.64 years in favor of SAVR. Despite risk adjustment, TAVR was associated with higher mortality (HR 1.42, 95% CI 1.17–1.73), with a reduction in RMST of 1.06 years. Two-stage meta-analyses yielded consistent findings with low-to-moderate heterogeneity. Conclusion: SAVR was associated with significantly lower mortality in patients with LFLG AS than TAVR, both before and after risk adjustment. While these findings suggest a potential survival benefit, the data are observational and hypothesis-generating, and residual confounding cannot be excluded.
- Open Access
- 16 April 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 270, 88-96
Impact of Prosthesis–Patient Mismatch After Surgical Mitral Valve Replacement: Systematic Review and Meta‐Analysis
- 16 April 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 270, 88-96
Open AccessImpact of Prosthesis–Patient Mismatch After Surgical Mitral Valve Replacement: Systematic Review and Meta‐Analysis
- 9 April 2026
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 122 (2) , 341-349
Impact of Circulatory Arrest Duration on Perioperative Mortality: Insights From More Than 1200 Aortic Arch Reconstructions
- 9 April 2026
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 122 (2) , 341-349
Impact of Circulatory Arrest Duration on Perioperative Mortality: Insights From More Than 1200 Aortic Arch Reconstructions
- Open Access
- 1 April 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (4)
Clamp On vs Off Impact of Distal Anastomotic Technique During Ascending Aortic Replacement in Acute Type A Aortic Dissection: IRAD Insights
Objectives: Most ascending aortic replacements for acute type A aortic dissection (ATAAD) are performed utilizing hypothermic circulatory arrest with an “open” distal anastomosis (“hemiarch”), whereas some are completed without ever removing the aortic cross-clamp. We sought to determine the impact of distal anastomotic technique in ascending aortic replacement for ATAAD repair. Methods: All patients in the IRAD Interventional Cohort database who underwent ATAAD repair between 2010 and 2020 were identified (n = 2559). Data for distal anastomotic technique were available in 2031 patients who underwent ascending aortic replacement, divided into 2 groups, based on whether they underwent hypothermic circulatory arrest (Clamp Off, n = 1900 [93.5%]) or not (Clamp On, n = 131, [6.5%]). We then propensity-matched 101 pairs of patients and analysed operative data and short- and mid-term outcomes. Results: In-hospital mortality for the unmatched population was 13.1% (266 deaths), not statistically different between the matched groups (Clamp Off, 11.0% vs Clamp On, 5.1% P = .22). There were no statistically significant differences observed in 3-year post-discharge survival curves between matched cohorts (Clamp Off, 89.5% vs Clamp On, 90.4%; stratified log-rank P-value = .46). Major perioperative complications (renal failure requiring dialysis, reoperation for bleeding, respiratory insufficiency) were not significantly different between the groups, notably including stroke (Clamp Off, 10.2% vs Clamp On, 5.8%, P = .32). Conclusions: In this propensity-matched cohort, postoperative mortality, major morbidity, and mid-term survival were comparable between open distal anastomosis and clamp-on strategies in selected patients undergoing ascending aortic replacement for ATAAD.
- 1 April 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (4)
Open AccessClamp On vs Off Impact of Distal Anastomotic Technique During Ascending Aortic Replacement in Acute Type A Aortic Dissection: IRAD Insights
Objectives: Most ascending aortic replacements for acute type A aortic dissection (ATAAD) are performed utilizing hypothermic circulatory arrest with an “open” distal anastomosis (“hemiarch”), whereas some are completed without ever removing the aortic cross-clamp. We sought to determine the impact of distal anastomotic technique in ascending aortic replacement for ATAAD repair. Methods: All patients in the IRAD Interventional Cohort database who underwent ATAAD repair between 2010 and 2020 were identified (n = 2559). Data for distal anastomotic technique were available in 2031 patients who underwent ascending aortic replacement, divided into 2 groups, based on whether they underwent hypothermic circulatory arrest (Clamp Off, n = 1900 [93.5%]) or not (Clamp On, n = 131, [6.5%]). We then propensity-matched 101 pairs of patients and analysed operative data and short- and mid-term outcomes. Results: In-hospital mortality for the unmatched population was 13.1% (266 deaths), not statistically different between the matched groups (Clamp Off, 11.0% vs Clamp On, 5.1% P = .22). There were no statistically significant differences observed in 3-year post-discharge survival curves between matched cohorts (Clamp Off, 89.5% vs Clamp On, 90.4%; stratified log-rank P-value = .46). Major perioperative complications (renal failure requiring dialysis, reoperation for bleeding, respiratory insufficiency) were not significantly different between the groups, notably including stroke (Clamp Off, 10.2% vs Clamp On, 5.8%, P = .32). Conclusions: In this propensity-matched cohort, postoperative mortality, major morbidity, and mid-term survival were comparable between open distal anastomosis and clamp-on strategies in selected patients undergoing ascending aortic replacement for ATAAD.
- Open Access
- 13 March 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (3) , 600-607
Sodium-glucose cotransporter 2 inhibitor use and outcomes after surgical aortic valve replacement
- 13 March 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (3) , 600-607
Open AccessSodium-glucose cotransporter 2 inhibitor use and outcomes after surgical aortic valve replacement
- 2 March 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 267, 104-108
Oversizing Transcatheter Aortic Valves: Are We Getting It Right?
- 2 March 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 267, 104-108
Oversizing Transcatheter Aortic Valves: Are We Getting It Right?
- Open Access
- 23 February 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (6) , 1718-1725
Balloon‐Expandable Versus Self‐Expanding Valves in Low‐Flow, Low‐Gradient Aortic Stenosis: Does Valve Type Matter?
Background: The optimal choice between balloon‐expandable (BE) and self‐expanding (SE) transcatheter heart valves (THVs) in patients with low‐flow low‐gradient aortic stenosis (LFLG AS) undergoing transcatheter aortic valve replacement (TAVR) remains unclear. Aims: This study aims to compare outcomes of BE THVs and SE THVs in patients with LFLG AS. Methods: This was a retrospective, single‐institution cohort study of TAVR procedures between 2012 and 2024. Patients with LFLG AS (mean gradient < 40 mmHg and ejection fraction < 50% or stroke volume index < 35 mL/m 2 ) were stratified by respective valve type. Patients with prior aortic valve replacement were excluded. Postoperative outcomes were compared between groups. Kaplan−Meier estimates and a Cox regression model were generated for survival. Cumulative incidence curves and a cause‐specific cox regression model were generated for heart failure (HF) readmission. Results: A total of 732 patients identified underwent TAVR for LFLG AS. Of these, 478 (65.3%) received a BE THV and 254 (34.7%) received a SE THV. STS PROM was similar between groups. There was no difference in 30‐day mortality between groups. SE THVs had a lower mean gradient but increased rates of paravalvular leak at 30 days post‐TAVR. Kaplan−Meier estimates were comparable between groups and there was no significant difference after multivariable analysis (HR 1.15, 95% CI 0.90−1.46, p = 0.27). Cumulative incidence estimates of HF readmission were similar between groups, however, BE THV was associated with reduced hazard of HF readmission on multivariable analysis (HR 0.77, 95% CI 0.59−0.99, p = 0.04). Conclusions: In patients with LFLG AS undergoing TAVR, BE and SE THVs have comparable midterm survival. BE THVs have a reduced risk of HF readmission on multivariable analysis.
- 23 February 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (6) , 1718-1725
Open AccessBalloon‐Expandable Versus Self‐Expanding Valves in Low‐Flow, Low‐Gradient Aortic Stenosis: Does Valve Type Matter?
Background: The optimal choice between balloon‐expandable (BE) and self‐expanding (SE) transcatheter heart valves (THVs) in patients with low‐flow low‐gradient aortic stenosis (LFLG AS) undergoing transcatheter aortic valve replacement (TAVR) remains unclear. Aims: This study aims to compare outcomes of BE THVs and SE THVs in patients with LFLG AS. Methods: This was a retrospective, single‐institution cohort study of TAVR procedures between 2012 and 2024. Patients with LFLG AS (mean gradient < 40 mmHg and ejection fraction < 50% or stroke volume index < 35 mL/m 2 ) were stratified by respective valve type. Patients with prior aortic valve replacement were excluded. Postoperative outcomes were compared between groups. Kaplan−Meier estimates and a Cox regression model were generated for survival. Cumulative incidence curves and a cause‐specific cox regression model were generated for heart failure (HF) readmission. Results: A total of 732 patients identified underwent TAVR for LFLG AS. Of these, 478 (65.3%) received a BE THV and 254 (34.7%) received a SE THV. STS PROM was similar between groups. There was no difference in 30‐day mortality between groups. SE THVs had a lower mean gradient but increased rates of paravalvular leak at 30 days post‐TAVR. Kaplan−Meier estimates were comparable between groups and there was no significant difference after multivariable analysis (HR 1.15, 95% CI 0.90−1.46, p = 0.27). Cumulative incidence estimates of HF readmission were similar between groups, however, BE THV was associated with reduced hazard of HF readmission on multivariable analysis (HR 0.77, 95% CI 0.59−0.99, p = 0.04). Conclusions: In patients with LFLG AS undergoing TAVR, BE and SE THVs have comparable midterm survival. BE THVs have a reduced risk of HF readmission on multivariable analysis.
- 17 February 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (3) , 591-599.e5
Association of GLP-1 inhibitors with cardiovascular outcomes in patients undergoing coronary artery bypass surgery
- 17 February 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (3) , 591-599.e5
Association of GLP-1 inhibitors with cardiovascular outcomes in patients undergoing coronary artery bypass surgery